US strategic oil reserve plunges to 44-year low — RT Business News
The stockpile has shrunk by nearly a third since Washington began releasing crude in March due to the Middle East…
September 2026
Read More
Logitech Pro X2 RAPID review: The keyboard that isn’t designed for me and you | Gaming | Entertainment
Logitech Pro X2 RAPID. (Image: Joshua Boyles) This article contains affiliate links, we will receive a commission on any sales…
Hong Kong firms lag mainland China on AI adoption amid legacy-system burden: Accenture
Hong Kong businesses are lagging behind their mainland Chinese peers in adopting artificial intelligence, as entrenched legacy systems and a…
Malaysia repatriates Myanmar migrants despite UN warnings
Buses accompanied by security vehicles, carrying migrants to a boat to be repatriated to Myanmar, arrived at a stadium near…
Logitech Pro X3 Superstrike review: The best gaming mouse just got even better | Gaming | Entertainment
Logitech Pro X3 Superstrike. (Image: Joshua Boyles) This article contains affiliate links, we will receive a commission on any sales…
As I see it | It’s the end of the world – and I don’t feel fine
Armageddon is what will happen when billionaires, or even trillionaires, are given free rein. Could this be the final outcome…
An endangered frog nursery in LA cares for hundreds of tadpoles until they’re ready for the wild
LOS ANGELES – The transition from tadpole to juvenile frog is never easy — legs sprout, tails shrink and lungs…
Andrew Scott fans demand Oscar for star’s role in Elsinore | Films | Entertainment
Film enthusiasts have been left deeply moved following the release of the trailer for Andrew Scott’s latest project, Elsinore, with…
China’s CXMT to favour domestic suppliers in US$5.2b memory-chip capacity push: source
Chinese memory chip giant ChangXin Memory Technologies (CXMT) plans to invest 34.9 billion yuan (US$5.2 billion) in expansion, with a…
AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows
Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while…